Orbem key facts
- Operator of an artificial intelligence-enabled imaging platform intended to generate non-invasive biological insights.
- It has raised $105.0M; the latest was Later Stage VC ($64.9M) in Jan 2026.
- Notable investors include MassChallenge, General Catalyst, European Innovation Council, EIT Food, StartLife — 28 tracked in total.
- Status: Privately Held (backing).
Who backs Orbem
28+- ·The complete investor list: 28 names
- ·Watch Orbem: the Monday email on marks, rounds and moves
Orbem funding rounds
No funding rounds for Orbem are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Orbem investors
28 investors are on record for Orbem, including MassChallenge, General Catalyst, European Innovation Council and EIT Food. By type, the record holds 7 venture capital firms and 2 private investors.
About Orbem
Operator of an artificial intelligence-enabled imaging platform intended to generate non-invasive biological insights. The company offers magnetic resonance imaging combined with advanced data analysis, rapid nondestructive assessment, and large-scale biological data interpretation, enabling food producers, researchers, and biological innovators to reduce waste, improve quality and transparency, and support more sustainable and health-focused decision-making.
- Sector
- Information Technology
- HQ
- Munich, Germany
- Founded
- 2018
- Employees
- 170
- Website
- orbem.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Orbem doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.